fda warning letters compounded semaglutide october 2025 Societies take stand against off-brand GLP-1s over safety concerns Beyond the Headlines: FDA Warning

doi: 10.1111/dom.12291 225 ZhaoHWeiRWangLTianQTaoMKeJet al

True pharmacological resistance to Retatrutide is extremely rare within the first year of treatment

This metabolic shift reduces 5-HT production, increases neurotoxin creation, and creates a self-perpetuating cycle where inflammation causes tryptophan metabolic imbalance, ultimately leading to neuronal damage that sustains inflammation (117)

Our patients use peptide therapy for body composition optimization, recovery acceleration after injury or training, sexual health support, appetite and weight regulation, cognitive performance, anxiety support, and anti-aging protocols

Clinical implications of cardiovascular outcome trials in type 2 diabetes